A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

Learn how GLP-1s are changing type 2 diabetes care, when insulin therapy is still necessary, and the benefits of combining ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Not sure what to expect when starting on a GLP-1? Get insights on how long it may take to start working, what results may be, and more. But these medications aren’t new. They’ve been around for ...

Researchers have found in a new study that Tirzepatide is more effective than conventional care for improving glycemic control and overall metabolic health in early type 2 diabetes.Tirzepatide ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the most promising effects of a new potential drug treatment for people with type ...

Blockbuster GLP-1 drugs such as Ozempic and Mounjaro are perhaps the most effective drugs ever developed for type 2 diabetes and obesity. And although they arent yet approved by the U.S. Food and Drug ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only is ...

Add Yahoo as a preferred source to see more of our stories on Google. Maryland Prescription Drug Affordability Chair Van T. Mitchell, shown here in a May 2024 meeting of the board in Annapolis. (Photo ...

There is a shift happening in diabetes care. Medicines still matter, but doctors are increasingly turning to something ...